Beatriz Mínguez

8.1k citations
77 papers · 6.5k · 3 hit papers · h-index 35

Impact in

  • Hepatology top 0.1%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Hepatitis C virus research
    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 45
    • Liver Disease and Transplantation 11
    • Hepatitis C virus research 6
    • Cancer Genomics and Diagnostics 6

Beatriz Mínguez

74 papers receiving 6.3k citations

Beatriz Mínguez's Hit Papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial 2023 · 374 citations
3740+2+4Years since publication100200300

Peers

Beatriz Mínguez
Comparison fields: 5 of 93
  • Hepatology 4k
  • Cancer Research 708
  • Oncology 614
  • Molecular Biology 1k
  • Epidemiology 444
Replace Stefano Caruso with:
Stefano Caruso France
Jae‐Jun Shim South Korea
Weidong Jia China
Enrico Narciso De Toni Germany
Minshan Chen China
Guo‐Ming Shi China
Bang‐De Xiang China
Matthew M. Yeh United States
Wen‐Ming Cong China
Zhao‐Chong Zeng China
Beatriz Mínguez relative to Stefano Caruso France Stefano Caruso's profile →
Citations per field
00.5×2×4×5.6×
Stefano Caruso · 1×
Citations per year

Countries citing papers authored by Beatriz Mínguez

Since Specialization
Citations

This map shows the geographic impact of Beatriz Mínguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Mínguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Mínguez more than expected).

Fields of papers citing papers by Beatriz Mínguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Mínguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Mínguez. The network helps show where Beatriz Mínguez may publish in the future.

Co-authors

The 25 scholars most cited alongside Beatriz Mínguez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beatriz Mínguez Line = papers co-authored together Beatriz Mínguez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008633
2 2008614
3
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2023374
4
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Hit paper breakdown →
2023326
5 2010271
6 2012271
7
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Hit paper breakdown →
2020244
8 2010217
9 2009198
10 2021198
11 2010197
12 2013192
13 2011189
14 2012189
15 2021163
16 2011155
17 2019155
18 2011127
19 2009124
20 2016118

About Beatriz Mínguez

Beatriz Mínguez is a scholar working on Hepatology, Cancer Research, Oncology, Epidemiology and Virology, having authored 77 papers that have together received 6.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease and Transplantation (11 papers), Hepatitis C virus research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Cardiac Valve Diseases and Treatments (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Hepatology (4k citations), Cancer Research (708 citations), Oncology (614 citations), Molecular Biology (1k citations) and Epidemiology (444 citations). Beatriz Mínguez has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Josep Maria Llovet, Augusto Villanueva, Anja Lachenmayer, Yujin Hoshida, Sara Toffanin, Juan Córdoba, Swan N. Thung, Laia Cabellos, Scott L. Friedman and Clara Alsinet. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Cancers, Alimentary Pharmacology & Therapeutics and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact